CSF2

Across TCGA pan-cancer cohorts, CSF2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CSF2 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher CSF2 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CSF2 expression acts as an unfavorable survival marker.

READ are the cancer types where CSF2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	All	0.269	0.819	.009	15	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

CSF2–READ (DFS)

Open the READ breakdown →